602 related articles for article (PubMed ID: 27402553)
1. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
2. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
3. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
4. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
[TBL] [Abstract][Full Text] [Related]
5. Prevention of chemotherapy-induced ovarian damage.
Roness H; Kashi O; Meirow D
Fertil Steril; 2016 Jan; 105(1):20-9. PubMed ID: 26677788
[TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review.
Iwase A; Nakamura T; Nakahara T; Goto M; Kikkawa F
Reprod Sci; 2015 May; 22(5):519-26. PubMed ID: 25228631
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
10. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
11. Effect of first line cancer treatment on the ovarian reserve and follicular density in girls under the age of 18 years.
El Issaoui M; Giorgione V; Mamsen LS; Rechnitzer C; Birkebæk N; Clausen N; Kelsey TW; Andersen CY
Fertil Steril; 2016 Dec; 106(7):1757-1762.e1. PubMed ID: 27717554
[TBL] [Abstract][Full Text] [Related]
12. [Statement: cancer treatments and ovarian reserve].
Basille C; Torre A; Grynberg M; Gallot V; Frydman R; Fanchin R
J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):433-43. PubMed ID: 20674192
[TBL] [Abstract][Full Text] [Related]
13. mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.
Goldman KN; Chenette D; Arju R; Duncan FE; Keefe DL; Grifo JA; Schneider RJ
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3186-3191. PubMed ID: 28270607
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
Szymanska KJ; Tan X; Oktay K
Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Endometriosis and Its Treatment on Ovarian Reserve.
Seyhan A; Ata B; Uncu G
Semin Reprod Med; 2015 Nov; 33(6):422-8. PubMed ID: 26594869
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of methamphetamine exposure in adolescent mice on the future ovarian reserve in adulthood.
Wang L; Qu G; Dong X; Huang K; Kumar M; Ji L; Wang Y; Yao J; Yang S; Wu R; Zhang H
Toxicol Lett; 2016 Feb; 242():1-8. PubMed ID: 26657179
[TBL] [Abstract][Full Text] [Related]
17. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.
Lutchman Singh K; Davies M; Chatterjee R
Hum Reprod Update; 2005; 11(1):69-89. PubMed ID: 15569700
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary.
Bedoschi GM; Navarro PA; Oktay KH
Panminerva Med; 2019 Mar; 61(1):68-75. PubMed ID: 29962184
[TBL] [Abstract][Full Text] [Related]
19. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies.
Di Paola R; Costantini C; Tecchio C; Salvagno GL; Montemezzi R; Perandini A; Pizzolo G; Zaffagnini S; Franchi M
Oncologist; 2013; 18(12):1307-14. PubMed ID: 24149138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
